Antony A Riley is CHIEF FINANCIAL OFFICER of Forte Biosciences, Inc.. Currently has a direct ownership of 30,776 shares of FBRX, which is worth approximately $617,058. The most recent transaction as insider was on Nov 21, 2024, when has been sold 22,514 shares (Common Stock) at a price of $5.55 per share, resulting in proceeds of $124,952. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.8K
84.65% 3M change
83.17% 12M change
Total Value Held $617,058

Antony A Riley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 21 2024
BUY
Open market or private purchase
$124,952 $5.55 p/Share
22,514 Added 42.25%
30,776 Common Stock
Oct 01 2024
SELL
Payment of exercise price or tax liability
$686 $5.16 p/Share
133 Reduced 1.58%
8,262 Common Stock
Oct 01 2024
BUY
Exercise of conversion of derivative security
-
375 Added 4.28%
8,395 Common Stock
Jul 01 2024
SELL
Payment of exercise price or tax liability
$1,839 $0.55 p/Share
3,345 Reduced 1.64%
200,504 Common Stock
Jul 01 2024
BUY
Exercise of conversion of derivative security
-
9,375 Added 4.4%
203,849 Common Stock
Apr 01 2024
SELL
Payment of exercise price or tax liability
$2,374 $0.71 p/Share
3,345 Reduced 1.69%
194,474 Common Stock
Apr 01 2024
BUY
Exercise of conversion of derivative security
-
9,375 Added 4.52%
197,819 Common Stock
Jan 01 2024
SELL
Payment of exercise price or tax liability
$3,149 $0.82 p/Share
3,841 Reduced 2.0%
188,444 Common Stock
Jan 01 2024
BUY
Exercise of conversion of derivative security
-
9,375 Added 4.65%
192,285 Common Stock
Oct 01 2023
SELL
Payment of exercise price or tax liability
$2,139 $0.66 p/Share
3,241 Reduced 1.74%
182,910 Common Stock
Oct 01 2023
BUY
Exercise of conversion of derivative security
-
9,375 Added 4.79%
186,151 Common Stock
Jul 31 2023
BUY
Grant, award, or other acquisition
$149,999 $1.01 p/Share
148,514 Added 45.66%
176,776 Common Stock
Jul 01 2023
SELL
Payment of exercise price or tax liability
$3,370 $1.04 p/Share
3,241 Reduced 11.57%
24,762 Common Stock
Jul 01 2023
BUY
Exercise of conversion of derivative security
-
9,375 Added 25.08%
28,003 Common Stock
Apr 01 2023
SELL
Payment of exercise price or tax liability
$3,273 $1.01 p/Share
3,241 Reduced 14.82%
18,628 Common Stock
Apr 01 2023
BUY
Exercise of conversion of derivative security
-
9,375 Added 30.01%
21,869 Common Stock
Sep 07 2021
SELL
Open market or private sale
$106,500 $4.26 p/Share
25,000 Reduced 69.32%
11,065 Common Stock
AAR

Antony A Riley

CHIEF FINANCIAL OFFICER
Torrance, CA

Track Institutional and Insider Activities on FBRX

Follow Forte Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FBRX shares.

Notify only if

Insider Trading

Get notified when an Forte Biosciences, Inc. insider buys or sells FBRX shares.

Notify only if

News

Receive news related to Forte Biosciences, Inc.

Track Activities on FBRX